全文获取类型
收费全文 | 1892142篇 |
免费 | 131367篇 |
国内免费 | 4213篇 |
专业分类
耳鼻咽喉 | 24529篇 |
儿科学 | 62992篇 |
妇产科学 | 51977篇 |
基础医学 | 266716篇 |
口腔科学 | 54313篇 |
临床医学 | 169780篇 |
内科学 | 367639篇 |
皮肤病学 | 42930篇 |
神经病学 | 143996篇 |
特种医学 | 73767篇 |
外国民族医学 | 343篇 |
外科学 | 286278篇 |
综合类 | 40147篇 |
现状与发展 | 4篇 |
一般理论 | 576篇 |
预防医学 | 143117篇 |
眼科学 | 44630篇 |
药学 | 137178篇 |
9篇 | |
中国医学 | 4604篇 |
肿瘤学 | 112197篇 |
出版年
2019年 | 14434篇 |
2018年 | 23971篇 |
2017年 | 19346篇 |
2016年 | 20180篇 |
2015年 | 23947篇 |
2014年 | 30924篇 |
2013年 | 42331篇 |
2012年 | 63397篇 |
2011年 | 62114篇 |
2010年 | 36062篇 |
2009年 | 34992篇 |
2008年 | 55394篇 |
2007年 | 59450篇 |
2006年 | 59903篇 |
2005年 | 64464篇 |
2004年 | 63961篇 |
2003年 | 57112篇 |
2002年 | 50984篇 |
2001年 | 95216篇 |
2000年 | 95315篇 |
1999年 | 81340篇 |
1998年 | 20405篇 |
1997年 | 17666篇 |
1996年 | 17762篇 |
1995年 | 17159篇 |
1994年 | 15628篇 |
1993年 | 14359篇 |
1992年 | 62779篇 |
1991年 | 61220篇 |
1990年 | 59222篇 |
1989年 | 56750篇 |
1988年 | 51718篇 |
1987年 | 50344篇 |
1986年 | 47404篇 |
1985年 | 44654篇 |
1984年 | 32485篇 |
1983年 | 27565篇 |
1982年 | 14806篇 |
1979年 | 28918篇 |
1978年 | 19727篇 |
1977年 | 16542篇 |
1976年 | 15340篇 |
1975年 | 16927篇 |
1974年 | 20552篇 |
1973年 | 19515篇 |
1972年 | 18255篇 |
1971年 | 17045篇 |
1970年 | 15802篇 |
1969年 | 14865篇 |
1968年 | 13834篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
11.
12.
13.
Clinical & Experimental Metastasis - 相似文献
14.
Hommes Franziska Mohsenpour Amir Kropff Dana Pilgram Lisa Matusall Svenja von Philipsborn Peter Sell Kerstin 《Bundesgesundheitsblatt, Gesundheitsforschung, Gesundheitsschutz》2022,65(1):96-106
Bundesgesundheitsblatt - Gesundheitsforschung - Gesundheitsschutz - Akteure der öffentlichen Gesundheit (Public Health) tragen wesentlich zu Gesundheitsschutz, -förderung und... 相似文献
15.
16.
17.
Adjuvant irradiation is the standard treatment after breast conservative surgery. Normofractionated regimen with an overall treatment time of 5 to 6 weeks is often considered as a limiting factor for irradiation compliance. In order to answer this issue, moderate and more recently extreme hypofractionated protocols appeared. We report here oncological outcomes and toxicity of hypofractionated breast irradiation. After defining the frame of moderate and extreme hypofractionated breast irradiations based on overall treatment time, patient selection criteria were listed. According to their levels of proof, the results of moderate and extreme hypofractionated breast irradiation were analysed. Overall treatment time for moderate hypofractionated breast irradiation ranged from 3 to 4 weeks, while for extreme hypofractionated breast irradiation, it was less than 1 week. For moderate hypofractionated breast irradiation, whole breast irradiation was currently performed with or without lymph node irradiation. Moderate hypofractionated breast irradiation has proven to be as safe and as efficient as normofractionated breast irradiation with level IA evidence. For extreme hypofractionated breast irradiation, phase III randomized trials confirmed that accelerated partial breast irradiation was non-inferior in terms of local control compared to normofractionated whole breast irradiation (with external beam radiation therapy and multicatheter brachytherapy), with similar acute and late toxicity. While the use of intraoperative breast irradiation remains under debate, new very accelerated partial breast irradiation (overall treatment time not exceeding 2 days) protocols emerged with encouraging results. Accelerated partial breast irradiation is warranted for extreme hypofractionated breast irradiation and is indicated for low-risk breast cancers. Moderate and extreme hypofractionated breast irradiation regimens are validated and can be routinely proposed according to patient selection criteria. 相似文献
18.
19.
Kuo-yi Jade Chang MHealthEc MHM BSc Lisa Lorraine Dillon MSpecEd BPsych Lil Deverell COMS PhD MEd GradDipO&M BEd Mei Ying Boon PhD BOptom FAAO Lisa Keay PhD MPH BOptom 《Clinical & experimental optometry》2020,103(4):434-448
Despite orientation and mobility (O&M) being a significant factor determining quality of life of people with low vision or blindness, there are no gold standard measures or agreement on how to measure O&M performance. In the first part of this systematic review, an inventory of O&M outcome measures used by recent studies to assess the performance of orientation and/or mobility of adults with vision impairment (low vision and blindness) is presented. A wide variety of O&M outcome measures have been implemented in different fields of study, such as epidemiologic research and interventional studies evaluating training, assistive technology, vision rehabilitation and vision restoration. The most frequent aspect of outcome measures is efficiency such as time, distance, speed and percentage of preferred walking speed, followed by obstacle contacts and avoidance, and dis/orientation and veering. Other less commonly used aspects are target identification, safety and social interaction and self-reported outcome measures. Some studies employ sophisticated equipment to capture and analyse O&M performance in a laboratory setting, while others carry out their assessment in real-world indoor or outdoor environments. In the second part of this review, the appropriateness of implementing the identified outcome measures to assess O&M performance in clinical and functional O&M practice is evaluated. Nearly a half of these outcome measures meet all four criteria of face validity (either clinical or functional), responsiveness, reliability and feasibility and have the potential to be implemented in clinical or functional O&M practice. The findings of this review confirm the complicated and dynamic nature of O&M. Multiple measures are required in any evaluation of O&M performance to facilitate holistic assessment of O&M abilities and limitations of each individual. 相似文献
20.